{"title":"Epidemiological and Clinical Profile Of Fever Related Retinitis: A Hospital Based Study","authors":"Soumya Harapanahalli Venkatesh","doi":"10.19070/2332-290x-2100093","DOIUrl":"https://doi.org/10.19070/2332-290x-2100093","url":null,"abstract":"","PeriodicalId":90865,"journal":{"name":"International journal of ophthalmology & eye science","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42904061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Optimizing Outcomes with Multifocal Intraocular Lenses","authors":"Alnoelaty ALmasri M.A","doi":"10.19070/2332-290X-2100091","DOIUrl":"https://doi.org/10.19070/2332-290X-2100091","url":null,"abstract":"Current present-day cataract surgery evolves from a visual restoration to a refractive approach. Greater independence from glasses and improvement of the quality of life were provided after surgery with the appearance of multifocal intraocular lenses (MF-IOLs). Since its creation in the 1980s, MFIOLs has undergone various technical improvements, including trifocal implants and implants with extended depth of vision. Excellent results were achieved thorough preoperative check, including the visual needs of the patients and the inherent eye anatomy. This analysis offers a broad overview of the various types of Mf-IOLs and rules for optimizing results through full preoperative screening and treatment postoperatively complications.","PeriodicalId":90865,"journal":{"name":"International journal of ophthalmology & eye science","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48182471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Role of Diabetes Mellitus in Causing Posterior Subcapsular Cataracts in Outpatients (Case From Indonesian Eye Hospital)","authors":"Nur Rizqillah","doi":"10.19070/2332-290x-2100095","DOIUrl":"https://doi.org/10.19070/2332-290x-2100095","url":null,"abstract":"","PeriodicalId":90865,"journal":{"name":"International journal of ophthalmology & eye science","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41599430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Do Ophthalmologists in India Over Prescribing Topical Antibiotics in Acute Infectious Conjunctivitis?","authors":"H. Kauser, R. Garg","doi":"10.19070/2332-290X-1900081","DOIUrl":"https://doi.org/10.19070/2332-290X-1900081","url":null,"abstract":"Inflammation or infection of the conjunctiva is known as conjunctivitis. It is characterized by dilatation of conjunctival vessels, hyperemia and edema of the conjunctiva and typically associated with discharge [1]. Conjunctivitis affects many people and imposes economic burden. Approximately 6 million people were affected annually with acute conjunctivitis in the United States [2]. The cost of treating bacterial conjunctivitis alone was estimated to be $377 million to $857 million per year [3]. Irrespective of the cause of conjunctivitis, in many US state health departments, students are required to be treated with topical antibiotic eye drops before returning to school [4].","PeriodicalId":90865,"journal":{"name":"International journal of ophthalmology & eye science","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42199393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Unusual Lesion of the Eyebrow: A Case Report of Chondroid Syringoma","authors":"Filali C.","doi":"10.19070/2332-290X-1900080","DOIUrl":"https://doi.org/10.19070/2332-290X-1900080","url":null,"abstract":"Chondroid syringoma is a rare mixed tumor accounting for only 0.01% of all primary skin tumors [1]. Though it’s very common occurrence is in head and the neck region, involvement of eyelids is extremely rare [2]. These are usually a slowly growing, asymptomatic, solitary, non ulcerating masses ranging between 0.5cm and 3.0cm in size [2]. Herein we report another rare case of chondroid syringoma of eyebrow in a young man.","PeriodicalId":90865,"journal":{"name":"International journal of ophthalmology & eye science","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42404227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Manual Small Incisional Cataract Surgery Learning Curve: Observational Comparison of Three Trainee Training","authors":"Anita T Girish, Soumya Hv, A. Singal","doi":"10.19070/2332-290x-1800079","DOIUrl":"https://doi.org/10.19070/2332-290x-1800079","url":null,"abstract":"1 DOMS, DNB, Associate Professor, Department of Ophthalmology, JSS Medical College and Hospital, Mysore, Karnataka, India. 2 MS, Associate Professor, Department of Ophthalmology, JSS Medical College and Hospital, Mysore, Karnataka, India. 3 MS, Junior Resident, Department of Ophthalmology, JSS Medical College and Hospital, Mysore, Karnataka, India. 4 DOMS, Junior Resident, Department of Ophthalmology, JSS Medical College and Hospital, Mysore, Karnataka, India.","PeriodicalId":90865,"journal":{"name":"International journal of ophthalmology & eye science","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41800343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Management of Recurrent Pterygium - A Case Report","authors":"A. Gupta, Verma Ak","doi":"10.19070/2332-290X-1800077","DOIUrl":"https://doi.org/10.19070/2332-290X-1800077","url":null,"abstract":"","PeriodicalId":90865,"journal":{"name":"International journal of ophthalmology & eye science","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47776475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Real-Life Clinical Effectiveness of Razumab® (World’s First Biosimilar Ranibizumab) in Wet Age- Related Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion: A Retrospective Pooled Analysis","authors":"S. Sharma, K. Ma, A. Chaturvedi","doi":"10.19070/2332-290X-1800076","DOIUrl":"https://doi.org/10.19070/2332-290X-1800076","url":null,"abstract":"Purpose: To evaluate the effectiveness of Razumab^® (world's first biosimilar ranibizumab; Intas Pharmaceuticals Ltd., India) in Indian patients with wet age-related macular degeneration (wet AMD), diabetic macular edema (DME) and retinal vein occlusion (RVO). Methods: RE-ENACT, a retrospective, multicenter study, analyzed pooled data of patients with wet AMD, DME, and RVO. Patients who had received ≥3 injections of Razumab^® between January and August 2016, were included. Endpoints were: improvement in best corrected visual acuity (BCVA, measured by logMAR/Snellen's chart), decrease in central macular thickness (CMT, measured by Spectral Domain Optical Coherence Tomography), and proportion of patients with intraretinal fluid (IRF) and subretinal fluid (SRF) at Weeks 4, 8 and 12. Results: Of 561 patients included, 348 (62.04%) were men. Mean ± SE BCVA improved from baseline (0.75 ± 0.01) to Week 4 (0.72 ± 0.01, p = 0.0318), attained significance at Week 8 (0.59 ± 0.01, p < 0.0001), which was maintained at Week 12 (0.49 ± 0.01, p < 0.0001). Mean ± SE CMT significantly (p < 0.0001) decreased from baseline (418.47 ± 4.78μm) to Weeks 4 (407.35 ± 4.65μm), 8 (342.10 ± 3.66μm), and 12 (301.17 ± 2.82μm). Proportion of patients with IRF and SRF significantly (p < 0.0001) decreased from baseline to Weeks 4, 8 and 12 (67.02% vs. 48.48%, 42.60%, and 34.22%, respectively for IRF; and 72.37% vs. 48.48%, 37.97%, 31.37%, respectively for SRF). No new safety concerns with biosimilar ranibizumab were observed. Conclusions: Razumab^® is effective in reducing macular thickness and improving visual acuity in patients with wet agerelated macular degeneration, diabetic macular edema, and retinal vein occlusion in routine clinical practice. Razumab^® demonstrated considerable effectiveness with no new safety concerns.","PeriodicalId":90865,"journal":{"name":"International journal of ophthalmology & eye science","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44358628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vellanki S, Ferrigno A, Alanis Y, Betts-Obregon Bs, Tsin At
{"title":"High Glucose and Glucose Deprivation Modulate Müller Cell Viability and VEGF Secretion.","authors":"Vellanki S, Ferrigno A, Alanis Y, Betts-Obregon Bs, Tsin At","doi":"10.19070/2332-290X-1600037","DOIUrl":"https://doi.org/10.19070/2332-290X-1600037","url":null,"abstract":"PURPOSE\u0000Diabetic retinopathy is manifested by excessive angiogenesis and high level of vascular endothelial growth factor (VEGF) in the eye.\u0000\u0000\u0000METHODS\u0000Human (MIO-M1) and rat (rMC-1) Müller cells were treated with 0, 5.5, or 30mM glucose for 24 hours. Viable cell counts were obtained by Trypan Blue Dye Exclusion Method. ELISA was used to determine VEGF levels in cell medium.\u0000\u0000\u0000RESULTS\u0000Compared to 24 hour treatment by 5.5mM glucose, MIO-M1 and rMC-1 in 30mM glucose increased in viable cell number by 38% and 24% respectively. In contrast, viable cells in 0mM glucose decreased by 28% and 50% respectively. Compared to 5.5mM, MIO-M1 and rMC-1 in 30mM glucose had increased levels of VEGF in cell medium (pg/ml by 24% and 20%) and also VEGF concentration in cells held in 0mM increased by 47% and 10% respectively. In both MIO-M1 and rMC-1, the amount of VEGF secreted per cell increased by about 100% when glucose was changed from 5.5 to 0mM but decreased slightly (17% in MIO-M1 and 11% in rMC-1) when glucose was increased from 5.5 to 30mM.\u0000\u0000\u0000CONCLUSIONS\u0000Our results show that MIO-M1 and rMC-1 are highly responsive to changes in glucose concentrations. 30mM compared to 5.5mM significantly increased cell viability but induced a significant change in VEGF secretion per cell in rMC-1 only. At 0, 5.5, and 30mM glucose, MIO-M1 secreted about 5-7-fold higher level of VEGF (pg/cell) than rMC-1. The mechanism of glucose-induced changes in rMC-1 and MIO-M1 cell viability and VEGF secretion remains to be elucidated.","PeriodicalId":90865,"journal":{"name":"International journal of ophthalmology & eye science","volume":"4 2 1","pages":"178-183"},"PeriodicalIF":0.0,"publicationDate":"2016-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68341468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}